Skip to content
Hot eventDeveloping

Isomorphic Labs raises $5B Series C for AI drug discovery

3 reports3 reporting sourcesUpdated 4 h ago

Start here

AI digest

Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital. Andreessen Horowitz joined as a new investor, alongside Alphabet and existing backers including GV, CapitalG, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund. The company says the funds will support building foundational biology models and advancing its in-house IsoDDE platform, moving its first therapeutic programs toward clinical trials. It is the second multibillion-dollar round in six months, following a $2.1 billion Series B in May 2026. Isomorphic Labs, led by Demis Hassabis, works with Novartis, Eli Lilly and Johnson & Johnson but has no approved drug yet. Drug discovery startups have raised a record $23.2 billion in 2026, according to Dealroom.

Generated from reports · updated 3 h ago

Report timeline

Follow the reports to see the event from different sides.

November 18
  1. Hacker News · AI
    Isomorphic Labs raises $5B Series C for AI drug discovery

    Isomorphic Labs, the AI drug discovery startup founded by former Google DeepMind chief Demis Hassabis, has raised a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet. The funds will support building foundational biology models and moving its first therapeutic programs toward clinical trials. Drug discovery startups have raised a record $23.2 billion in 2026, according to Dealroom, and Isomorphic last raised a $2.1 billion Series B in May.

November 17
  1. The Decoder
    Isomorphic Labs raises $5 billion in second mega-round within six months

    Alphabet's AI drug discovery company Isomorphic Labs has raised $5 billion, its second billion-dollar round in six months, after a $2.1 billion round in May 2026. Greenoaks and Sequoia Capital co-led the round, with new backer Andreessen Horowitz joining Alphabet and existing investors, and the funds will advance its in-house IsoDDE platform and push its drug pipeline toward clinical trials. The company, led by Demis Hassabis, works with Novartis, Eli Lilly and Johnson & Johnson but has no approved drug yet.

  2. TechCrunch · AI
    Isomorphic Labs raises $5B Series C to push drug candidates toward clinical trials

    Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and existing backers including GV, Capital G, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund participating.

Heat for this event

Current, comparable range
25
Peak, comparable range
27November 18 05:00
Change in 24 hours
–

The trend compares the same participants over hours observed continuously, so its range can be narrower than the current heat count. Hover or tap the chart for hourly heat; the arrow keys move through it.